Appendix 2:
Cycle | Docetaxel |
Capecitabine |
Bevacizumab |
|||||||||
N | Median total dose administered | Median dose level administered | Full dose received | N | Median total dose administered | Median dose level administered | Full dose received | N | Median total dose administered | Median dose level administered | Full dose received | |
mg | mg/m2 | % | mg | mg/m2 | % | mg | mg/m2 | % | ||||
1 | 45 | 136 | 75 | 100 | 45 | 36 400 | 825 | 98 | 45 | 1100 | 15 | 100 |
2 | 40 | 126 | 75 | 58 | 40 | 33 650 | 825 | 60 | 41 | 1084 | 15 | 100 |
3 | 36 | 120 | 60 | 47 | 36 | 32 200 | 660 | 44 | 37 | 1050 | 15 | 100 |
4 | 32 | 120 | 60 | 47 | 28 | 28 950 | 660 | 25 | 33 | 1010 | 15 | 100 |
5 | 31 | 120 | 60 | 45 | 26 | 31 625 | 660 | 23 | 32 | 1005 | 15 | 100 |
6 | 27 | 115 | 60 | 44 | 22 | 31 625 | 660 | 23 | 29 | 1000 | 15 | 100 |
7 | 22 | 117 | 62 | 45 | 19 | 28 000 | 660 | 26 | 23 | 1074 | 15 | 96 |
8 | 18 | 115 | 62 | 44 | 16 | 28 000 | 660 | 19 | 22 | 1060 | 15 | 95 |
9 | 14 | 119 | 62 | 43 | 13 | 32 200 | 660 | 23 | 18 | 1084 | 15 | 94 |
10 | 13 | 117 | 60 | 38 | 12 | 30 100 | 660 | 25 | 18 | 1084 | 15 | 94 |